You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pexidartinib

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tenosynovial Giant Cell Tumor Trial in Japan (Pexidartinib)

Recruiting
  • Tenosynovial Giant Cell Tumor
  • Pexidartinib
  • Aichi, Japan
  • +5 more
Jun 29, 2022

Tenosynovial Giant Cell Tumor Trial in Worldwide (Pexidartinib)

Active, not recruiting
  • Tenosynovial Giant Cell Tumor
  • Pexidartinib
  • Scottsdale, Arizona
  • +15 more
Apr 29, 2022

Moderate Hepatic Impairment Trial in Miami, Orlando (Pexidartinib)

Completed
Has Results
  • Moderate Hepatic Impairment
  • Pexidartinib
  • Miami, Florida
  • +1 more
Jun 11, 2021

Colorectal Cancer, Pancreatic Cancer, Metastatic Cancer Trial in Lyon, Toulouse (Pexidartinib, Durvalumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Lyon, France
  • +1 more
Sep 2, 2021

Gastrointestinal Stromal Tumor (GIST) Trial in New York (MEK162, Pexidartinib)

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 29, 2021

Drug Interaction Potential Trial in Worldwide (Tolbutamide, Midazolam, Pexidartinib)

Completed
Has Results
  • Drug Interaction Potential
  • Scottsdale, Arizona
  • +10 more
Apr 19, 2021

Gastrointestinal Stromal Tumors Trial in United States (PLX9486, Pexidartinib, Sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
  • +5 more
Apr 30, 2021

Pharmacokinetics in Healthy Volunteers Trial in San Antonio (Pexidartinib, Probenecid)

Completed
  • Pharmacokinetics in Healthy Volunteers
  • San Antonio, Texas
    Worldwide Clinical Trials Early Phase Services
May 1, 2017